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Abstract 
Inherited maculopathies, age related macular degeneration and some forms of retinitis 
pigmentosa are associated with impaired function or loss of the retinal pigment epithelium 
(RPE). Among potential treatments, transplantation approaches are particularly promising. 
The arrangement of RPE cells in a well-defined tissue layer makes the RPE amenable to 
cell or tissue sheet transplantation. Different cell sources have been suggested for RPE 
transplantation but the development of a clinical protocol faces several obstacles. The 
source should provide a sufficient number of cells to at least recover the macula area. 
Secondly, cells should be plastic enough to be able to integrate in the host tissue. Tissue 
sheets should be considered as well, but the substrate on which RPE cells are cultured 
needs to be carefully evaluated. Immunogenicity can also be an obstacle for effective 
transplantation as well as tumorigenicity of not fully differentiated cells. Finally, ethical 
concerns may represent drawbacks when embryo-derived cells are proposed for RPE 
transplantation. Here we discuss different cell sources that became available in recent 
years and their different properties. We also present data on a new source of human RPE. 
We provide a protocol for RPE differentiation of retinal stem cells derived from adult ciliary 
bodies of post-mortem donors. We show molecular characterization of the in vitro 
differentiated RPE tissue and demonstrate its functionality based on a phagocytosis assay. 
This new source may provide tissue for allogenic transplantation based on best matches 
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5.2 Molecular characterization of the in vitro generated RPE 
5.3 Phagocytosis activity of RPE cells in the newly formed sheets of tissue 








The retinal pigment epithelium (RPE) is a highly specialized epithelium with a 
neuroectodermal embryonic origin like the retina. While the retina was first described by 
Galen in the second century A.D., discovery of the RPE required the use of the first 
rudimentary microscopes in the 18th century and was described by Carlo Mondini of 
Bologna in his “Commentationes Bononienses” (1790) as “a real membrane formed by 
innumerable globules which makes an excessively delicate network” (Marmor and 
Wolfensberger, 1998). The histology of the RPE was then elucidated at the end of the 19th 
century and further characterized in more recent times.  
The eyes derive from two evaginations of the forebrain that generate the optic vesicles 
connected to the brain by the optic stalks. The optic vesicles then invaginate to form the 
optic cups with the outer layer destined to become the RPE. The outer stratum is a 
monolayer of cells that differentiate during embryonic/fetal development and is 
characterized by pigmentation, which appears during the 5th week of human 
embryogenesis. RPE differentiation is induced by several factors including the signaling 
molecule Activin, a member of the TGF family, which is secreted by adjacent 
mesenchymal cells. These signals induce expression of transcription factors, such as 
microphthalmia-associated transcription factor (MITF), orthodenticle homolog 2 (OTX2) 
and paired box 6 (PAX6), that are essential for RPE specification and to drive expression 
of proteins necessary for the distinguishing functions of the RPE (Bharti et al., 2012; 
Fuhrmann et al., 2000; Housset et al., 2013). The fully differentiated RPE consists of a 
polarized monolayer of pigmented cells with a basal side adherent to the Bruch’s 
membrane, which separates the RPE from the choroid, and an apical membrane facing 
the photoreceptor cells.  
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In this paper we summarize molecular and functional characteristics of the RPE tissue 
since the characterization of these features is required when RPE is generated in vitro. We 
also discuss RPE impairment and diseases that will be amenable to cell replacement 
strategies. We review several stem cell sources to produce RPE in vitro. Finally, we 
present a new protocol for the differentiation of adult human retinal stem cells into RPE 
sheets.  
 
2. Molecular and functional characteristics of the RPE and related diseases 
 
2.1 Molecular and structural characteristics of RPE cells 
RPE cells are characterized by asymmetrical distribution of molecules at the cell surface 
and compartmentalization of the organelles in the cytoplasm (Figure 1). Morphological 
differences between apical and basal membranes are infoldings at the basal membrane 
and microvilli at the apical side. The apical projections not only increase the apical cell 
surface but also envelop photoreceptor cell outer segments (POS) and mediate the 
turnover of the tip of the photoreceptors cells through phagocytosis. Organelles and 
cytoskeleton filaments are localized differently along the apicobasal axis. The nucleus and 
mitochondria are found at the basal side of RPE cells and pigmented melanosomes are 
transferred to the apical zone where they orient parallel to the incoming light. During 
differentiation, adherens junctions form among adjacent cells and are mediated by 
cadherins, namely cadherin 2 (N-cadherin) and cadherin 3 (P-cadherin) (Burke et al., 
1999; Lagunowich and Grunwald, 1989; Murphy-Erdosh et al., 1994). Formation of 
adherens junctions is followed by the formation of circumferential bundles of actin 
filaments to build zonula adherens junctions (Nabi et al., 1993; Owaribe and Masuda, 
1982; Williams and Rizzolo, 1997). This remodeling affects the cytoskeleton leading to the 
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development of distinct apical, lateral and basal membrane territories hosting specific 
proteins. Gap-junctions in the lateral membrane are transmembrane channels that mediate 
cell-cell communication between adjacent RPE cells. Connexin 43 is one of the 
components of the gap-junctions in the RPE tissue and was reported to play a role in 
differentiation of RPE cells (Kojima et al., 2008). The apical and basolateral domains are 
segregated by tight junctions and different proteins and lipids are specifically sorted to the 
two compartments. For example, the basolateral side of the RPE cell harbors the chloride 
channel bestrophin 1 (Marmorstein et al., 2000; Sun et al., 2002). Na+/K+ ATPase can be 
found preferentially at the apical plasma membrane of RPE cells, rather than at the 
basolateral membrane as in most epithelial cells (Caldwell and McLaughlin, 1984). In fact, 
RPE cells exhibit a reversed polarity compared to other epithelial cells and the specific 
localization of the Na+/K+ ATPase appears to be directed by the preferential expression of 
N-cadherin compared to E-cadherin (Burke et al., 2000). Members of the ezrin/moesin 
family of actin-binding proteins are localized at the apical plasma membrane in RPE cells 
(Höfer and Drenckhahn, 1993) and apical microvilli are characterized by the expression of 
v5 integrin (Finnemann et al., 1997).  
 
2.2 RPE function in photoreceptor outer segment turnover 
The RPE serves several functions that are essential for vision and survival of retinal 
neurons and several eye diseases are caused by impairments of these functions. One of 
the most important functions of the RPE is the removal and degradation of the tips of POS 
(Figure 2A). Phagocytosis of POS distal tips follows a circadian rhythm and is triggered by 
light. The direct role of the RPE in phagocytosis was demonstrated more than 40 years 
ago by radioactive amino acid delivery as a pulse and detection of radioactive 
phagosomes inside the RPE (Young and Bok, 1969). Young and Bok also demonstrated 
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that RPE cells actively participate in the disposal of POS distal tips because radioactive 
phagocytized POS were then eliminated from RPE cells. In the renewal process POS are 
newly built at the base of the outer segment while the tip of the outer segment contains the 
highest concentration of old and photo-damaged proteins and lipids that need to be 
removed. Through coordinated POS tip shedding and new POS production a constant 
length of the POS is maintained. Diurnal binding of POS to the RPE is mediated by v5 
integrin through the secreted glycoprotein milk fat globule-EGF 8 (MFG-E8) that acts as a 
ligand mediating the binding of POS to v5 integrin via its RGD motif (Finnemann et al., 
1997; Nandrot and Finnemann, 2006; Nandrot et al., 2007, 2004). The scavenger receptor 
CD36, a transmembrane glycoprotein in the RPE, acts in POS uptake through detection of 
oxidized phospholipids but not in initial binding of POS (Ryeom et al., 1996; Sun et al., 
2006). CD36 is also involved in the clearance of oxidized low-density lipoprotein subretinal 
deposits (Picard et al., 2010). Nevertheless, v5 integrin is not necessary for POS 
internalization. Internalization of POS requires c-mer proto-oncogene tyrosine kinase 
(MERTK), a receptor activated upon tyrosine phosphorylation by focal adhesion kinase 
(FAK), a downstream effector of v5 integrin (D’Cruz et al., 2000; Vollrath et al., 2001). 
MERTK ligands, such as growth arrest specific protein 6 (GAS6), Tubby and protein S, 
also play important roles in POS phagocytosis (Caberoy et al., 2010; Finnemann, 2003; 
Hall et al., 2005, 2001). Finally, cathepsin D, a lysosomal enzyme, participates to the 
degradation of internalized POS (Rakoczy et al., 1997). Impaired phagocytic function of 
the RPE is associated with subretinal accumulation of POS and rapid degeneration of 
photoreceptors as in Retinitis Pigmentosa (RP) caused by mutation in MERTK (D’Cruz et 
al., 2000; Gal et al., 2000; Vollrath et al., 2001). Murine models lacking v5 integrin or 
CD36 also display compromised phagocytosis leading to blindness (Houssier et al., 2008; 
Nandrot et al., 2004).  
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2.3 Role of the RPE in the visual cycle 
Another fundamental function of the RPE is retinoid recycling (Figure 2B). Absorption of a 
photon of light by rhodopsin causes isomerisation of the chromophore from 11-cis retinal 
to all-trans-retinal, which is released from opsin. In order to reconstitute rhodopsin, all-
trans retinal must be converted back to 11-cis retinal through a multistep pathway called 
visual cycle. The visual cycle begins in the photoreceptor outer segment discs where the 
ATP-binding cassette subfamily A member 4 (ABCA4) transfers all-trans retinal from the 
intradiscal membrane surface to the cytoplasmic membrane surface (Sullivan, 2009). The 
all-trans-retinal is then reduced to all-trans retinol by retinol dehydrogenases (RDH8 and 
RDH12) (Belyaeva et al., 2005; Chen et al., 2012). All-trans retinol is transported through 
the interphotoreceptor matrix to the RPE by the interphotoreceptor retinoid-binding protein 
(IRBP) (Okajima et al., 1989). All-trans retinol is also supplied to the RPE by the choroidal 
vasculature and enters the RPE cells in a receptor-mediated process involving recognition 
of a serum retinol-binding protein/transthyretin (RBP/TTR) complex by the STRA6 receptor 
(Kawaguchi et al., 2007; Pfeffer et al., 1986). Within the RPE, all-trans retinol is bound to 
the cellular retinaldehyde-binding protein (CRALBP) encoded by the RLBP1 gene (Saari et 
al., 1982). The conversion of all-trans retinol to 11-cis retinal requires an enzymatic 
cascade involving at least three enzymes associated with the RPE smooth endoplasmic 
reticulum. The reaction starts with esterification of all-trans retinol to all-trans retinyl esters 
by the enzyme lecithin:retinol acyltransferase (LRAT) (Ruiz et al., 1999; Saari et al., 1993). 
Then an isomerohydrolase, called retinal pigment epithelium-specific protein 65kDa 
(RPE65), catalyses the concerted hydrolysis of all-trans retinyl ester and the isomerization 
to 11-cis retinol (Jin et al., 2005; Moiseyev et al., 2005; Redmond et al., 2005). 11-cis 
retinol dehydrogenase (RDH5) converts 11-cis retinol to the final product 11-cis retinal 
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(Driessen et al., 1995; Simon et al., 1995). 11-cis retinal then exits the RPE and combines 
with the opsin protein in photoreceptor cells to form the visual pigment. This step is 
mediated by IRBP with its capacity to remove 11- cis retinal from membranes (Carlson and 
Bok, 1999). In many human retinal dystrophies the visual cycle is disturbed resulting in the 
inability to either produce an adequate supply of 11-cis retinal or a failure to remove 
intermediate retinoid products.  
 
2.4 Polarization of the RPE 
Photoreceptors are tightly interdigitated with RPE microvilli and this is required to maintain 
the retina in a fixed plane necessary for the optics, as well as for exchange of nutrients 
and oxygen from the choriocapillaris to the photoreceptors. This exchange is strictly 
regulated by the RPE (Figure 2C). The tight nature of the subretinal space between RPE 
and retina necessitates fluids to be kept out. Under physiological conditions aquaporins, 
water channel proteins, allow water transport apical to basal through RPE cells at a rate of 
2 to 18 μL/cm2 per hour (Stamer et al., 2003) and in cases of RPE detachment a transport 
of fluid could be confirmed in human RPE (Chihara and Nao-i, 1985). Tight junctions 
among RPE cells provide a barrier against the passage of substances from the fenestrated 
choroidal capillaries to the retina and generate the external blood-retinal barrier. Electrical 
parameters can be recorded with RPE tissue mounted in an Ussing chamber and the 
difference between resting potentials of apical and basolateral membranes in the RPE 
generates a transepithelial potential that is linked to the different types and distribution of 
ion channels and other transporters (Gallemore et al., 1993). A specific and regulated 
traffic of ions either in the retina-to-choroid or choroid-to-retina directions relies on the RPE. 
The RPE actively transports Cl- and HCO3
- from the retina to the choroid and Na+ in the 
opposite direction (Miller and Edelman, 1990). Cl- enters through an apical membrane 
 11 
Na+-K+-2Cl- co-transporter and is extruded at the basolateral membrane. The basolateral 
membrane is characterized by the presence of several chloride channels including cystic 
fibrosis transmembrane conductance regulator (CFTR) and bestrophin 1 (Weng et al., 
2002). Bestrophin 1 is a homo-oligomeric integral membrane protein forming anion 
channels (Marmorstein et al., 2000; Stanton et al., 2006). Bestrophin 1 transports Cl- in a 
Ca2+ dependent manner but may also have intracellular functions not well characterized 
yet (Qu and Hartzell, 2008; Strauss et al., 2014). Mutations in the BEST1 gene encoding 
for bestrophin 1 are linked to Best Vitelliform Macular Dystrophy (Marquardt et al., 1998; 
Petrukhin et al., 1998). Ion channels in RPE cells are important to buffer ion changes in 
response to light stimuli because light induces a decrease of K+ ion concentration in the 
subretinal space that causes hyperpolarization of the apical membrane of the RPE and 
activation of inward rectifier K+ channels. The K+ conductance is electrically coupled to the 
basolateral Cl- conductance and this coupling is important for buffering the chemical 
composition of the subretinal space (Bialek and Miller, 1994). The RPE also secrets 
trophic factors (Figure 2C) such as the pigment epithelium-derived factor (PEDF), a protein 
implicated in the survival and normal function of the retina (Barnstable and Tombran-Tink, 
2004). PEDF is found in the healthy human eye and its levels are altered in eyes affected 
by retinal degenerative processes (Holekamp et al., 2002; Mohan et al., 2012; Ogata et al., 
2004, 2002; Wang et al., 2013). The basal side of the RPE secretes the vascular 
endothelial growth factor (VEGF-A), required to maintain the choroidal circulation 
(Marneros et al., 2005; Saint-Geniez et al., 2009). VEGF-A is target of therapies for wet 





2.5 Pigmentation of the RPE 
Melanogenesis in the RPE is fundamental for sight as reduced pigmentation causes vision 
impairment. Melanin is synthesized inside intracellular organelles called melanosomes. 
Melanosome biogenesis requires sequential maturation stages involving morphological 
and molecular changes (Figure 2D). Before melanin is deposited, intraluminal fibrillar 
sheets composed of the premelanosomal protein 17 (PMEL17) assemble inside 
melanosomes (Berson et al., 2001). Melanin biosynthesis enzymes, i.e. tyrosinase, 
tyrosinase-related protein 1 and Dopachrome tautomerase, are then delivered to the 
developing organelles and are necessary for the deposition of the black pigment (Raposo 
and Marks, 2007). Melanosome organellogenesis requires coordinated trafficking of 
proteins that involves adaptor-protein complexes (AP-1 and AP-3) (Dell’Angelica, 2009). 
Other proteins residing on the melanosomes are the P-protein (pink-eyed dilution homolog 
protein, OCA2), membrane-associated transport protein (MATP, OCA4) and the 
melanosome-specific G-protein coupled receptor called ocular albinism type 1 
(GPR143/OA1). All these proteins are linked to different forms of albinism (Bassi et al., 
1995; Brilliant, 2001; Newton et al., 2001; Oetting and King, 1994). The fully pigmented 
and mature melanosomes are stored within the RPE and contain black eumelanin. Two 
shapes can be observed in melanosomes: ellipsoid granules (1 m in diameter and 2-3 
m in length) are primarily located at the apical portion and spherical granules reside in 
the mid-portion of the cell. Melanosomes redistribute to the apical processes of the RPE 
after light onset and this movement is mediated by Rab27a, melanophilin, and myosin Va 
(Futter et al., 2004). Melanin contributes to vision by preventing light reflection in the 
fundus and by protecting photoreceptors from an excess of dispersed light. Pigment 
granules are important not only for absorption of light but they also protect from oxidative 
stress and are involved in the binding of zinc and drugs (Schraermeyer and Heimann, 
 13 
1999; Ugarte and Osborne, 2014). Pigmentation in the RPE also influences ganglion cell 
projections and fovea development but the molecular mechanisms have not been well 
characterized yet. 
 
2.3 RPE in retinal diseases 
The RPE plays important roles in vision: absorption of stray light, formation of the blood-
retinal barrier, regeneration of visual pigments and phagocytosis of the tip of POS (Strauss, 
2005). Several retinal diseases are caused by loss or failing of one of these functions. 
Albinism represents a group of genetic abnormalities due to defects in melanogenesis in 
the RPE. All albino patients have decreased visual acuity due to fovea hypoplasia and loss 
of stereoscopic vision due to the misrouting of the optic tracts (Harvey et al., 2006; 
Summers, 2009). During development, embryonic ganglion cell axons must find their way 
out of the retina into the optic nerve and extend along the optic tract to reach targets in the 
central nervous system. In the optic chiasm retinal axons segregate to pass into the optic 
tracts on either the same side (ipsilateral) or the opposite side of the brain (contralateral). 
The albino visual pathway is abnormal because of a reduction in the number of ipsilateral 
projecting ganglion cells. The molecular mechanisms regulating optic nerve formation and 
fovea development have not been completely elucidated and it is still not well understood 
why RPE pigmentation is necessary for these developmental processes (McAllister et al., 
2010; Rachel et al., 2002; Rebsam et al., 2012). Albinism is not always associated to 
reduced melanin synthesis but can also be due to reduced number of melanosomes that 
likewise results in reduced pigmentation. In fact, mutations in the OA1 gene, causing 
ocular albinism type 1, affect melanosome biogenesis leading to decreased melanosome 
number and formation of aberrant organelles (Cortese et al., 2005; Giordano et al., 2009). 
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As discussed above, a key role of the RPE in maintaining a healthy and functional retina 
resides in its tight association with photoreceptor cells. Any disruption of the 
photoreceptor-RPE complex may lead to various degrees of loss of visual function, 
depending not only on the biological severity of the disease process, but also on the 
region of the retina that is primarily affected. Several inherited and degenerative diseases, 
such as RP, inherited maculopathies (e.g. Stargardt Disease (STGD), Vitelliform Macular 
Distrophy (VMD)) and the dry form of age related macular degeneration (AMD), are 
associated with impaired RPE functions or loss of the photoreceptor-RPE complex.  
STGD is the most common form of juvenile macular dystrophy leading to severe central 
vision loss. Autosomal recessive STGD is caused by mutations in the ABCA4 gene that is 
also linked to other retinal degeneration phenotypes (Klevering et al., 2005). Impaired 
function of ABCA4 results in accumulation of toxic all-trans retinal derivatives in the 
photoreceptor outer segments, and following phagocytosis by RPE cells, all-trans retinal is 
converted to N-retinylidene-N-retinylethanolamine (A2E) and related bisretinoids that are 
the major components of lipofuscin. Rupture of lipofuscin-filled RPE cells leads to the end 
stage of the disease with loss of RPE and photoreceptors. The exact sequence of cell 
degeneration leading to photoreceptor and RPE atrophy in STGD remains controversial, 
with recent evidences of early photoreceptor anomalies (Gomes et al., 2009; Ritter et al., 
2013) adding to the consolidated hypothesis that RPE damage occurs initially, with 
secondary photoreceptor degeneration (Eagle et al., 1980; Steinmetz et al., 1991). 
Nevertheless, it is interesting to note that mutations in a gene expressed in photoreceptors 
may lead to substantial impairment of RPE cells. Hence, we should be cautious in defining 
a priori the therapeutic potential of a given cell therapy based solely on the gene defect 
location, and improving our knowledge on the details of cell degeneration in different 
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stages of a disease may become a critical element in deciding whether and when to 
initiate cell therapy, i.e. in defining the indications for a novel treatment. 
The majority of the known mutations causing RP are associated with genes expressed in 
rod photoreceptors, however also genes specifically expressed in RPE, such as genes 
encoding for visual cycle enzymes (LRAT, RPE65, RDH5), can cause RP. Progressive 
degeneration in RP first leads to rod photoreceptor loss but subsequently affects also 
cones as well as the RPE with the formation of pigment depositions in the retina visible 
with fundus examination, hence the term “pigmentosa” for this family of retinal dystrophies 
(Koenekoop, 2009; Sancho-Pelluz et al., 2008; Wright et al., 2010).  
No cure has been found yet for treating retinal degeneration, but several strategies are 
achieving initial results. These approaches can be divided into two broad groups: (1) those 
aiming at restoring health and function of surviving cells through gene supplementation 
(Bainbridge et al., 2008; Cideciyan et al., 2008; Cremers et al., 2002; Hauswirth et al., 
2008; Maguire et al., 2008; Smith et al., 2009) or by treatments with neuroprotective 
molecules to slow the degeneration process (Frasson et al., 1999; Hamel, 2006; Léveillard 
and Sahel, 2010; Nakazawa et al., 2011; Punzo et al., 2009; Sieving et al., 2006), and (2) 
those attempting to restore retinal photosensitivity. The latter includes electronic retinal 
implants (Chader et al., 2009; Zrenner, 2002; Zrenner et al., 2011), optogenetic 
approaches (Busskamp et al., 2012), and cell implantation therapies (Gust and Reh, 2011; 
MacLaren et al., 2006; West et al., 2010). An effective cell therapy can act through 
different mechanisms: transplanted cells may secrete trophic/neuroprotective factors to 
slow degeneration or provide new photoreceptors to replace lost cells. In the latter case 
not only implanted cells need to survive and function as phototransducers, but they also 
have to form functional synapses with second order retinal neurons. Moreover, implanted 
photoreceptor cells cannot survive and be active without a functional RPE that almost 
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invariably is affected at some stage of the disease process. Developing a combined 
RPE/photoreceptor sheet for transplantation might be a solution in the future, but at 
present cell therapy approaches are focusing on the implantation of one cell type (either 
photoreceptor or RPE cells) selecting conditions where the other cell type is still present. 
This approach appears more feasible in diseases where RPE cells degenerate first, 
subsequently leading to photoreceptor loss and thus to blindness, as it occurs in some 
common macular diseases, like dry AMD and STGD. As functional recovery depends on 
photoreceptor rescue by implanted healthy RPE cells, it will be critical to treat patients 
early in the disease process and before extensive damage occurs. Although success rates 
are not high, case numbers low and no long-term follow-up is available, the positive 
outcomes described in some patients treated with macular translocation and RPE patch 
grafts confirmed that replacement of diseased RPE can improve vision and thus are 
encouraging the development of new cell-replacement therapeutic approaches (Ong and 
da Cruz, 2012; Skaf and Mahmoud, 2011). Developing a safe therapy with RPE cells 
might become useful in the treatment of many of the retinal degenerative diseases 
affecting the RPE-photoreceptor complex. After several attempts to transplant the retina, 
researchers are still evaluating the molecular features characterizing cells with the ability 
to generate a functional RPE suitable for cell therapy of the diseased retina.  
There are several elements that researchers need to account for when developing such 
therapeutic tools. Therapeutic potentials and transplantation procedures have to face the 
need for 40,000-60,000 RPE cells to replace the macula area (Lu et al., 2009). Current 
Good Manufacturing Practices (cGMPs) are required to monitor the facility, processes, 
testing, and practices to produce a consistently safe and effective product for human use. 
In the context of clinical manufacturing of a cell therapy product Current Good Tissue 
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Practices (cGTP) are also required to oversee donor consent, traceability, and infectious 
disease screening.  
Transplantation of allogenic or autologous RPE aims at replacing pathological RPE with 
healthy tissue. Several cell sources have been evaluated for RPE replacement therapies 
including immortalized cell lines (i.e. ARPE19) as well as other non-RPE cell lines or 
sheets of fetal and adult RPE (Pinilla et al., 2007; Algvere et al., 1997; Chen et al., 2009; 
Tezel et al., 2007). Autologous peripheral RPE have also been transplanted in AMD 
patients (Binder et al., 2002; van Meurs and Van Den Biesen, 2003). Only partial rescue of 
vision could be shown in these studies and translation into the clinic was hindered by the 
limited accessibility to these cells or by ethical concerns. Furthermore, prenatal tissue may 
be very variable with regards to quality. Lately, studies focused on the search of new cell 
sources to overcome these limitations and to offer in vitro culture techniques that allow the 
expansion of homogeneous cells to gain numbers suitable for cell replacement therapies.  
 
3. Generating RPE in vitro 
 
3.1 Embryonic stem cells and induced pluripotent stem cells as sources of RPE 
Embryonic stem cells (ESCs) originate from the inner cell mass of the mammalian embryo 
at the blastocyst stage that is reached at 5 days post-fertilization in humans. Stem cells 
can be classified according to the range of cell types they can differentiate into: pluripotent 
stem cells can give rise to all embryonic cell types and multipotent stem cells have the 
ability to differentiate only in a limited number of cell types related to the tissue from which 
the stem cell derived from. ESCs are defined as pluripotent cells, able to proliferate 
indefinitely and to differentiate into any cell type given the appropriate environment and 
stimuli.  
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ESCs have been envisaged as an important source to generate RPE in vitro in sufficient 
amount for transplantation purposes. Differentiation methods both for mouse and human 
ESCs are based on either spontaneous or defined culture procedures (Ramsden et al., 
2013). In order to induce spontaneous differentiation, ESCs were grown to confluence on 
a feeder layer of PA6 stromal cells and when basic fibroblast growth factor (bFGF) was 
withdrawn from the culture medium pigmented clones spontaneously formed and were 
subsequently isolated and expanded (Kawasaki et al., 2002). A second protocol required 
that ESC were first grown as embryoid bodies and then plated on dishes coated either 
with laminin and fibronectin or with gelatin until they formed visible pigmented colonies (Lu 
et al., 2009; Osakada et al., 2008). The RPE tissue generated by these methods 
expressed many RPE-specific proteins, formed tight junctions and showed apical-basal 
polarity. Molecularly directed methods to differentiate RPE from ESCs were based on 
blocking the Wnt and Nodal signaling pathways or on exposure to Nicotinamide and 
Activin A or on treatment with bFGF, Retinoic acid and Sonic hedgehog (Idelson et al., 
2009; Osakada et al., 2009; Zahabi et al., 2012). ESC-derived pigmented cells could form 
a cell monolayer with polygonal actin bundles, as defined by the staining with F-actin, and 
with tight-junctions as shown by localization of the tight junction protein zona occludens 1 
(ZO-1). These cells were shown to express PAX6, at levels similar to fetal RPE, and MITF, 
a key regulator of RPE differentiation (Bharti et al., 2012). The presence of mature RPE 
specific markers, such as the visual cycle enzyme RPE65, could also be demonstrated. 
Ultrastructural analysis revealed that ESC-derived RPE formed a polarized tissue with 
apical microvilli. Electron microscopy also showed melanosomes mostly at the apical side 
of the cells. Molecularly controlled differentiation procedures, however, required very long 
culture times and, so far, did not show enough benefits compared to the spontaneous 
method to justify their application for therapeutic purposes. 
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Given the origin of ESCs it is clear that the prospective application of their derivatives to 
cell transplantation in patients may raise significant ethical concerns. More recently, a new 
source of pluripotent cells was developed from adult murine somatic cells, such as 
fibroblasts, that could be reprogrammed to a pluripotent state by misexpression of four 
transcription factors: OCT4, SOX2, KLF4, c-MYC (OSKM). The reprogrammed cells were 
called induced pluripotent stem cells (iPSCs) (Takahashi and Yamanaka, 2006). iPSCs 
share all the desirable self-renewal and pluripotency characteristics of ESCs, without 
carrying the ethical burden associated to the use of human embryos. Furthermore, iPSCs 
can be derived from patients, thus allowing for the development of personalized cell 
therapies and of in vitro models for molecular studies of diseases. Protocols for RPE 
differentiation of ESCs were also successfully applied to murine and human iPSCs, 
showing their equivalence to ESCs (Hirami et al., 2009; Osakada et al., 2009).  
Provided that many ethical obstacles can be overcome by the use of iPSC derived RPE, 
the in vitro generated tissue can be envisaged as a promising source for cell replacement 
therapies because it displays many of the features of native RPE such as pigmentation, 
apical-basal polarity, tight-junctions, phagocytosis activity and expression of enzymes for 
the visual cycle. The eye is also an immune-privileged location thanks to the blood-retina 
barrier making this organ a favorable site for tissue transplantation therapies.  
Pre-clinical evaluation of integration competence of in vitro differentiated cells were 
undertaken by subretinal injections of human ESC-derived RPE into retinal degeneration 
rodent models or into the immune-deficient NIH III mouse model (Haruta et al., 2004; Lu et 
al., 2009). Visual acuity was measured by optomotor response in a mouse model for 
STGD and a rat model of RP. This test revealed a rescue of spatial acuity when at least 
50,000 cells were injected. Luminance threshold responses recorded across the superior 
colliculus showed that the area with the best sensitivity was the treated area. Treated eyes 
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maintained better luminance thresholds five months after surgery when compared to the 
contralateral uninjected eye that had lost light sensitivity at this age. Rescue was 
confirmed by histological analysis showing integration of human donor RPE cells into the 
host RPE layer. Additionally, subretinal transplantation of RPE derived from human iPSCs 
into young (2 days old) Rpe65rd12/Rpe65rd12 mutant mice confirmed no tumor formation 
from transplanted cells and, most importantly, restoration of vision as measured by ERG at 
the age of 6 months (Li et al., 2012). Finally, a safety study demonstrated that ESC-
derived RPE did not form teratomas when injected into immune-deficient NIH III mice up to 
9 months after transplantation (Lu et al., 2009).   
These studies paved the way for clinical applications in patients. A cell line of ESC-derived 
RPE called MA09-hRPE was used in phase I and II clinical trials. MA09-hRPE cells were 
injected into the submacular space of one patient affected by STGD and one patient 
affected by dry AMD. The follow-up at four months did not show any evidence of teratoma 
formation and no loss of vision in treated eyes. Some vision improvement was reported 
(Schwartz et al., 2012). 
 
3.2 Adult RPE as a source of RPE 
Mature RPE cells are mitotically quiescent under physiological conditions in the eye. 
Several studies on amphibians showed that, upon injury, the RPE could proliferate and 
regenerate both RPE and neural retina. These findings demonstrated intrinsic plasticity of 
RPE cells and ability to transdifferentiate. These observations also suggested that the 
RPE has some capacity for self-repair upon proper stimuli. Plasticity of the human RPE 
cells was also uncovered in pathological conditions, for example in proliferative 
vitreoretinopathy, in which epithelial-mesenchymal transition and proliferation was reported 
(Casaroli-Marano et al., 1999). RPE cultures derived from adult human donors could be 
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propagated in vitro, however the identification of two phenotypically distinct cell 
populations suggested some heterogeneity in the culture (McKay and Burke, 1994). Long 
post-confluent periods were required for adult RPE cells to form tissue sheets and mature 
adherens junctions (Kaida et al., 2000). The prospective use of adult RPE in regenerative 
therapy was recently reconsidered when a subpopulation of RPE cells was discovered to 
exhibit self-renewal ability in vitro and multipotentiality (Salero et al., 2012). After 
dissociation of RPE cells from human donor eyes, pigmented cells were able to reactivate 
proliferation when plated on an adherent substrate in the presence of growth factors from 
serum. Cells could reach confluence and formed a cobblestone monolayer that expressed 
several RPE specific genes but at lower levels compared to adult RPE. These cells highly 
expressed c-MYC and KLF4 but not other stemness markers such as OCT4 and NANOG. 
About 10% of the primary culture cells could be passaged and expanded in vitro to form 
new cobblestone RPE monolayers (Salero et al., 2012). Although the source of RPE cells 
from adult eyes could open interesting perspectives to autologous transplantation, 
expression of genes involved in cell proliferation and cancer in these cultures may act as a 
drawback in the use of this tissue source for cell therapy because of the possible 
development of tumors from the transplanted cells. Complete in vitro differentiation into a 
mature RPE monolayer prior to transplantation was recently shown to limit these harmful 
outcomes (Stanzel et al., 2014).  
 
3.3 Retinal neurospheres (RNS) as source of RPE 
Retinal stem cells (RSCs) have been identified in the adult ciliary body and these cells can 
be cultured in vitro as pigmented neurospheres. The procedure requires dissection of the 
ciliary epithelium followed by dissociation of the cells and culture at very low density to 
generate floating clones of pigmented cells called retinal neurospheres (RNS) (Ahmad et 
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al., 2000; Tropepe et al., 2000). Molecular analysis of these cells showed that they derive 
from large pigmented ciliary epithelial cells expressing low levels of P-cadherin (Ballios et 
al., 2012). Pigmented RNS can be obtained from different species such as man, rat, 
mouse, pig and rabbit (Coles et al., 2004; Gu et al., 2007; Inoue et al., 2005; Ahmad et al. 
2000) and are visible within one week of in vitro culture with serum-free DMEM-F12 
medium in the presence of hormones and defined doses of growth factors. RNS show a 
limited ability to be expanded in vitro because only a small proportion of cells in a 
neurosphere have self-renewal capability. Since in vitro expansion is very important to 
obtain large amount of cells necessary for therapeutic purposes, the protocol for in vitro 
culture and propagation was ameliorated by treatment with PEDF, a potent anti-
angiogenic and neuroprotective agent of the retina (De Marzo et al., 2010). Molecular 
characterization implied that RNS have features of retinal progenitors. Interestingly, when 
compared to ESCs, RNS expressed much higher levels of retinal neuroblast transcription 
factors (PAX6, CHX10 and RAX) but lower levels of NANOG, OCT3/4 and SOX2, 
suggesting that RNS contained cells with characteristics of retinal progenitors with only a 
small population of stem cells (Demontis et al., 2012). RNS from the adult ciliary 
epithelium are therefore colonies of a mixed population of cells exhibiting retinal stem and 
progenitor nature. Ultrastructural analysis confirmed some heterogeneity in the cells 
composing RNS and identified a central area characterized by polymorph cells with 
cytoplasmic processes and a peripheral area characterized by flat, elongated and 
polarized epithelial-like cells containing melanosomes (Moe et al., 2009).  
RNS from rodent ciliary bodies could be induced to differentiate into all neural retinal cell 
types and into RPE (Aruta et al., 2011; Tropepe et al., 2000; Vossmerbaeumer et al., 
2008). Differentiation into rod photoreceptors was optimized in vitro by culturing with 
DMEM-F12 supplemented with defined factors in the presence of bFGF (Ballios et al., 
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2012; Demontis et al., 2012). Otherwise, differentiation of murine RNS into RPE required 
plating of RNS onto extracellular matrix from Engelbreth-Holm-Swarm murine sarcoma 
(ECM) and switching the culture medium from DMEM-F12 to DMEM in the absence of 
bFGF. DMEM supplemented with serum and hormones (Hydrocortisone, Selenious acid, 
Linoleic acid, Insulin, Transferrin, Putrescine and Triiodothyronine) allowed the generation 
of a RPE monolayer (Aruta et al., 2011). Initially cells migrated out of the RNS and lost 
pigmentation but after 7 days in culture, when cells reached confluence, they started to 
pigment again. During this time in culture, cells specifically differentiated into RPE as 
demonstrated by change of expression of the different isoforms of the pigment cell master 
gene Mitf. Differentiated cells specifically expressed a RPE specific isoform of Mitf, i.e. H-
Mitif, and switched off M-Mitf which is typical of skin and choroidal melanocytes (Bharti et 
al., 2008). In vitro differentiated cells expressed the melanin biosynthesis enzymes 
Tyrosinase, Tyrosinase–related protein 1 and Dopachrome tautomerase and as well as 
genes important for melanosome biogenesis and transport such as Pmel17, Matp, Oca2, 
Oa1, Mlana and Myo7a. RNS could be induced to differentiate into a monolayer of 
pigmented cells connected by tight-junctions and gap-junction, labeled by ZO-1 and 
Connexin 43, respectively. A longer differentiation time was required to detect expression 
of markers characteristic of mature RPE such as Rpe65, the visual cycle enzyme. At this 
time of differentiation cells showed a polarized phenotype characterized by the basolateral 
membrane localization of Bestrophin 1 and the apical localization of Ezrin, 5-integrin and 
Na+/K+ATPase. Electron microscopy analysis showed melanosomes at different 
differentiation stages and with an elongated shape typical of RPE melanosomes. This 
study also demonstrated phagocytosis activity in RNS-derived RPE cells that were able to 
uptake POS by binding to V5 integrin and internalization mediated by Mertk.  
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Published studies on the murine tissue suggested that the ciliary body can be a promising 
source of cells to generate RPE for transplantation purposes (Aruta et al., 2011). While 
ESCs are already used in clinical trials and are paving the way for subretinal 
transplantation procedures, there is still need for accessible sources of cells without the 
ethical burdens of ESC. The ciliary body appears to be a fairly accessible tissue that can 
be easily collected from post-mortem donors. Nevertheless, in case efficient isolation 
techniques become available, partial ciliectomy surgical procedures may be considered on 
patients to allow autologous transplantation. Here we will discuss improvement of the 
procedures to generate a highly pigmented and differentiated human RPE tissue that may 
provide a source for cell therapy approaches in the future. 
 
4. Generation of human RNS from post-mortem donations 
 
4.1 Tissue collection and dissociation 
The procedures of the present study involving human participants were approved by the 
local ethical committee, and were conducted in accordance with the principles of the 
Declaration of Helsinki (http://www.wma.net/en/60about/70history/01declarationHelsinki/). 
Human ciliary bodies were collected from deceased donors after their legal 
representatives had expressed a written informed consent for the inclusion in the study. 
Donors were not affected by retinal degeneration and had an age between 70 and 85 
years. After disinfection with povidone iodine, the conjunctiva and Tenon’s capsule were 
dissected for 12 clock hours and a concentric scleral cut was performed 12 clock hours 
with a blade and curved scissors preserving the integrity of the uveal tissue. The 
corneoscleral graft was then explanted and a circular cut was done posteriorly to the pars 
plicata and containing the ciliary bodies. The ciliary bodies, the lens and the iris 
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were finally explanted en-bloc and preserved at 4°C in a synthetic media for corneal 
storage (EUSOL-C®).  
For cell preparation, the iris was separated from the pars plicata, and the lens and the 
capsule were removed. The cleaned pars plicata was cut into 4 portions and treated with 
2mg/ml of dispase in DMEM-F12 medium for 30 min at 37°C. The pieces of ciliary body 
were then moved to a solution containing 1.3mg/ml of trypsin and 0.67mg/ml of 
hyaluronidase and incubated for 20 minutes at 37°C. The ciliary body epithelium was 
scraped from the ciliary muscle and dissociated to a single cell suspension (for a detailed 
protocol see Giordano et al., 2007). We obtained an average of 6x105 cells per eye. 
 
4.2 RNS culture 
Cells dissociated from the ciliary body were seeded at the density of 20,000 cells/ml and 
cultured with DMEM-F12 medium added with N2 supplement (Gibco), 20ng/ml of EGF and 
20ng/ml of bFGF. Floating clones of cells were visible 2-3 days after plating. Clones 
consisted of pigmented cells that did not attach to the plastic substrate of the Petri dish 
(Figure 3A), as previously published for RNS (Aruta et al., 2011; Demontis et al., 2012; 
Giordano et al., 2007). After 7 days in culture RNS reached a diameter of about 100m 
(Figure 3A-C). At different time points cell proliferation in RNS was assessed by exposure 
to 10 M BrdU (5-bromo-2'-deoxyuridine) for 3 hours followed by immunofluorescence with 
an anti-BrdU antibody to detect the newly incorporated nucleotide in the genomic DNA. 
Cells in the RNS were actively proliferating during the first days of culture when most 
nuclei were positive to BrdU staining (Figure 3D). The number of proliferating cells 
decreased with time in culture and no proliferation could be detected after 9 days (Figure 
3E-F). Based on the proliferation assay we chose to start differentiation of RNS at the 7th 
day of culture. 
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5. In vitro differentiation of RNS into human RPE  
 
5.1 Differentiation of RPE sheets from RNS 
We modified the published protocol for murine RNS and we seeded human RNS cells after 
dissociation for 30 min with AccutaseTM (Millipore). We obtained about 1.2x105 cells per 
eye that underwent differentiation into RPE. Dissociated cells were seeded on an ECM 
substrate at the concentration of 23,000 cells/cm2 and cultured for 2 days with the RNS 
growth medium containing bFGF and EGF. On the 3rd day of culture growth factors were 
withdrawn and cells were exposed to differentiation medium as previously published (Aruta 
et al., 2011). Cells actively proliferated during the first days of differentiation and 
proliferation was still high after 7 days of culture (75%, Figure 3G-H and M). Interestingly, 
proliferation could be detected in poorly pigmented cells (Figure 3G, red arrows). After 14 
days of differentiation the number of BrdU labeled cells decreased to less than 10% and 
after 21 days of culture proliferating cells were approximately 3% (Figure 3I-M). The 
decreasing number of proliferating cells correlated with increased differentiation and 
pigmentation, since we observed BrdU positive cells only in poorly pigmented regions 
(Figure 3G-L). After 21 days of culture in differentiation medium cells formed a pigmented 
monolayer (Figure 3K). 
 
5.2 Molecular characterization of the in vitro generated RPE 
Molecular characteristics of the RPE cells derived from RNS in vitro were evaluated by 
immunofluorescence analysis, western blotting and real-time qPCR. The specificity of 
staining with different antibodies was confirmed using the Madin-Darby Canine Kidney 
(MDCK) epithelial cell line as control (Figure 4C, F, I, L, O). We first assessed the 
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formation of tight junctions by immunostaining with an antibody against the protein ZO1. 
ZO1 displayed membrane localization in cells after 21 days of differentiation when they 
formed a confluent monolayer of polygonal cells (Figure 4A-B). Polarization of the RPE 
cells was assessed with three markers: 5-integrin and ezrin which are located at the 
apical side of the RPE and bestrophin 1 at the basolateral membrane.5-integrin, 
necessary for binding of POS during phagocytosis, could be detected with an apical 
localization in cells at all differentiation time points (Figure 4D-E and P). Similarly, Ezrin 
showed an apical localization at 7 and 21 days of differentiation (Figure 4G-H). Bestrophin 
1 showed basolateral localization at all time points, as expected in RPE cells (Figure 4J-K 
and Q). We also evaluated the expression of visual cycle enzymes either by 
immunofluorescence or western blotting. We could detect LRAT inside the RPE cells, as 
demonstrated by confocal microscopy (Figure 4M-N). RPE65 was clearly present in RPE 
cells after 21 days of differentiation in vitro but the amount of protein was much lower 
compared to adult human RPE (Figure 5A-B). Similarly, CRALBP, necessary for the 
binding of retinoids inside the RPE, was observed at all times of differentiation but at lower 
levels compared to expression in mature human RPE (Figure 5A-B). 
A key transcription factor necessary for RPE differentiation is MITF. MITF is characterized 
by different isoforms and H-MITF is one of the isoforms specific for RPE cells and is not 
expressed by other pigmented cells of the eye (Bharti et al., 2008). Primers for real-time 
qPCR were designed such as they could discriminate at the mRNA level among several 
MITF isoforms (Aruta et al., 2011). Expression of the RPE specific H-MITF isoform showed 
highest expression levels at 21 days of differentiation (Figure 5C). Interestingly, expression 
increased with differentiation and the levels at 21 days were higher than in the adult 
human RPE. To confirm that the MITF transcription factor localized, as expected, in the 
nuclei of RPE cells we used an anti-MITF antibody and found very low MITF in RPE cells 
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differentiated for 7 days. Strong and nuclear specific immunostaining was observed in 
RPE cells after 14 days of differentiation (Figure 5D-E).  
Finally, we wanted to define if in vitro differentiated RPE expressed PEDF, a trophic factor 
with neuroprotective properties (Barnstable and Tombran-Tink, 2004). RPE cells 
differentiated for 21 days showed a detectable expression of PEDF mRNA although 
expression levels were much lower compared to adult RPE (Figure 5F). Progressive 
pigmentation of cells with differentiation time inferred that melanin synthesis enzymes 
were active in the RPE cultures (Figure 3G, I and K). We thus also assessed expression of 
one of the genes important for melanosome biogenesis, OA1. OA1 transcripts could be 
detected after 21 days of differentiation and displayed higher levels than in the adult RPE 
(Figure 5G). It is known that melanosomes are not actively regenerated in the fully mature 
RPE and therefore some genes involved in melanogenesis are down-regulated in adult 
RPE. The observation of a higher level of OA1 mRNA in RPE cells in vitro compared to the 
RPE from adult donors may be explained by the fact that RPE cultures at 21 days have 
not reached full maturation, as also suggested by the levels of expression of other RPE 
markers (Figure 5A-C). Consistent with this hypothesis a previous report showed that the 
OA1 gene is expressed at low levels in adult RPE (Surace et al., 2000).   
 
5.3 Phagocytosis activity of RPE cells in the newly formed sheets of tissue 
A phagocytosis assay was performed to test one of the functions of RPE cells in the tissue 
differentiated in vitro. To define the phagocytic ability of in vitro differentiated RPE we used 
fluorescein labeled bovine POS, as previously published (Aruta et al., 2011). RPE cells 
differentiated for 21 days were fed for 1 or 3 hours with POS. We assessed whether RPE 
cells were able to internalize fluorescein labeled POS by confocal microscopy. Intracellular 
localization of POS in RPE cells confirmed the phagocytic ability of the RPE tissue 
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differentiated in vitro (Figure 5H). Increased internalization of POS was observed over time 
of exposure (Figure 5I), in agreement with studies of phagocytosis in primary RPE cell 
cultures (Kennedy et al., 1994). 
 
6. Future directions  
 
In vitro differentiated human RPE derived from ESCs have been transplanted subretinally 
as cell suspension for the treatment of AMD and STGD in phase I and II clinical trials 
(Clinical Trial ID# NCT01344993, NCT01226628). Initial reports confirmed that the 
treatment is safe but the efficacy is still under review. The scientific community is still 
debating the best cell source for RPE transplantation. Technical and clinical limitations 
should also be considered and among them the surgical procedure that may require either 
injection of a cell suspension or transplantation of RPE tissue sheets, the number of cells 
necessary for effective treatments, immunogenic responses and ethical issues. 
In this paper we discussed different cell sources for RPE transplantation, such as fetal 
tissue, adult RPE cells, ESCs and iPSCs as well as RSCs. Some of the limitations in the 
use of fetal sources for transplantation of RPE reside in the variable quality of the tissue 
after harvest and in the immunogenicity. ESCs and iPSCs exhibit clinically appealing 
features including limited immunogenicity and, for iPSCs, the possibility to use an 
autologous cell source. Unlike iPSCs or other potential modalities of autologous cell 
transplantation, ESCs cells are allogenic hence they carry the drawback of not being 
genetically matched to the recipient patient. Cell therapies using allogenic lines may 
induce immune response in the host, leading to the rejection of the transplanted cells. 
Immunosuppressive therapy may be used to prevent and counteract the immune reaction, 
but its side effects can be severe. The development of technologies capable of reducing 
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the immunogenicity of in vitro expanded RPE cells, or even to ensure immunological 
compatibility with the patient would definitely facilitate the application of cell therapies. 
iPSCs express low levels of MHC class one and 2-microglobin proteins at their surface 
but expression of these proteins increases upon differentiation into RPE (Kamao et al., 
2014). Hence grafts of in vitro differentiated RPE derived from allogenic iPSC may evoke 
immune response with subsequent rejection. Furthermore, the surgical procedure for 
transplantation can induce some degree of inflammation to which the transplanted tissue 
will be exposed. Another complication of the surgery can be the possible reflux of 
transplanted cells into the vitreous that may be dangerous and cause proliferative 
vitreoretinopathy (PVR). PVR is the main complication following retinal detachment 
surgery or retinal injury. It is characterized by migration and proliferation of retinal cells 
onto the retinal surface and into the vitreous. Although they are not the only cell type 
involved, RPE cells play a major role in the pathogenesis of PVR (Casaroli-Marano et al., 
1999; Leaver, 1995). 
Implants of an adult RPE cell suspension have been tried as autologous transplants but 
drawbacks were found in the difficulty to collect enough cells to repopulate the macula 
area and in the limited competence of cells in suspension to attach to a diseased Bruch’s 
membrane and to form a functional RPE monolayer in AMD patients (Sheridan et al., 
2004). Transplantation of a polarized RPE monolayer as a sheet is thus envisaged as the 
most promising protocol for successful rescue of vision in patients. In fact, the apicobasal 
polarity is essential for the RPE functionality. The basal and basolateral sides need to be 
properly organized to ensure a functional outer blood-retina barrier. The apical microvilli for 
phagocytosis of POS and transfer of retinoids in the visual cycle are also important. A 
comparison of transplantation of cell suspensions versus RPE sheets both differentiated 
from iPSC was evaluated in monkeys. RPE cells transplanted as a cell suspension 
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accumulated at the lower margin of the induced retinal detachment and some cells 
refluxed into the vitreous. RPE transplanted as a sheet was detected in the transplanted 
site and, in case of autograft transplant using iPSC derived from a biopsy from the same 
monkey, did not show signs of rejection one year after surgery (Kamao et al., 2014). 
Several studies are evaluating the best substrate for the culture of a continuous RPE 
monolayer (Sheridan et al., 2004). The identification of a clinically usable artificial scaffold 
is still under study because biodegradable membranes can cause inflammation and 
nondegradable membranes can interfere with functional exchanges between the RPE and 
the choroid.  
The most appealing feature of the RPE tissue differentiated in vitro is the possibility to 
expand the cells before differentiation. In this study we presented a new possible source of 
human RPE from RSCs culture as RNS. The advantage of RPE derived from RNS is the 
relatively large availability of the cell source, as ciliary bodies can be collected from post-
mortem donors for allograft transplantation. Secondly, the possibility of autologous 
transplantation upon partial ciliectomy surgery may be evaluated. We showed that a single 
donor can provide enough cells for several transplants so partial ciliectomy may provide 
enough cells for autologous transplantation. On the other hand, autologous transplantation 
from patients with genetic RPE defects would require an ex-vivo gene therapy correction 
of the genetic mutation prior to the in vivo use of the tissue. The protocol of RPE 
differentiation from RNS required limited cell expansion in vitro and short time in culture 
compared to ESC or iPSC. Short cultures will limit possible chromosomal aberrations that 
are linked to cell transformation. In fact, a disadvantage of ESCs and iPSCs in clinical 
applications is the possibility of tumor formation from residual undifferentiated cells in the 
RPE cell product for transplantation. Tumorigenicity tests were recently performed on RPE 
derived from iPSC via subcutaneous and subretinal administration and this RPE source 
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had a negligible tumorigenic potential (Kanemura et al., 2014). RNS-derived RPE tissue 
has not been evaluated in tumorigenicity tests yet, but data shown in this study provided 
evidence that RPE derived from RNS stopped proliferation upon differentiation. Further 
analyses will be required to fully characterize RNS-derived RPE and its characteristics 
when cultured on matrixes suitable for tissue transplantation. 
Another issue discussed more recently in transplantation studies is the differentiation 
stage that RPE cells need to reach before transplantation. Photoreceptors were shown to 
be able to integrate in the host tissue if they were postmitotic but not fully differentiated 
(MacLaren et al., 2006). Similarly, not heavily pigmented cells attached better to the 
Bruch’s membrane suggesting that the control of in vitro differentiation before 
transplantation may allow optimization of cell survival and functionality (Schwartz et al., 
2012). RPE cells derived from RNS did not reach a fully differentiated stage, based on the 
gene expression studies presented here. A full characterization of the differentiation level 
of this tissue will require microarray analysis followed by comparison with fetal and adult 
human RPE.  
The ability of the recipient eye to accept the transplanted cells may also be affected by 
factors present in a fully differentiated tissue and by the unhealthy environment. The 
modulation of the recipient environment by ectopic expression of IGF1 helped the 
integration of transplanted cells in a photoreceptor transplantation murine model (West et 
al., 2012). It is possible that integration of RPE may also be facilitated by supplementation 
of growth factors during transplantation. 
Finally, the success in restoring vision via cell therapy with RPE cells will ultimately 
depend on the presence of residual photoreceptors in the retina. Hence, it is critical that 
adequate diagnostic tools are available to accurately visualize and quantify photoreceptor 
cells, and to improve the characterization of the Bruch’s membrane and choriocapillaris. 
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The confocal near-infrared reflectance (NIR) imaging and the Spectral-domain optical 
coherence tomography (SD-OCT) were recently shown in preclinical studies to be able to 
detect transplanted human ESC derived RPE cells in Royal College of Surgeons (RCS) rat 
in vivo (Hu et al., 2012; Ribeiro et al., 2013). Most recent OCT technologies already 
provide high resolution images of the RPE-photoreceptor complex, but more advanced 
features would be desirable, such as extending high density 3D scanning to larger retinal 
areas, and automatizing the extraction of measurements from such high volume data. 
Such improvements in diagnostics tools will allow a more accurate classification and 
selection of the cases to be treated, a better identification of the preferred retinal location 
for cells transplantation, as well as more quantitative data in follow-up studies. 
In conclusion, data from preclinical studies as well as ongoing clinical trials show evidence 
that the proposed stem cells sources (ESCs, iPSCs, RSCs) may all represent viable 
solutions for RPE transplantation, although a number of open questions need to be 
addressed by future studies in order to define the best option not only in terms of cell type, 
but also of tissue engineering and of surgical technique. Moreover, it is reasonable to 
expect that different options may become available in the future, and that their different 
features may be advantageous for different clinical situations. Finally, RPE transplantation 
might become part of complex therapeutic strategies in some diseases, e.g. STGD, in 
which RPE transplantation could be combined with gene therapy to halt the metabolic 
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Figure 1. Schematic representation of RPE cells and their polarized phenotype.  
RPE cells show asymmetric distribution of proteins in apical and basolateral membrane 
domains. The apical membrane is characterized by microvilli and is separated from the 
basolateral membrane by tight junctions. Actin filaments form the circumferential 
microfilament bundles that attach to the zonula adherens. Gap junctions mediate 
communication between RPE cells. The basal membrane is characterized by infoldings 
and attaches to its basal lamina and to the Bruch’s membrane. Melanosomes are 
represented with black round and oval shapes and mitochondria with ellipsoidal shapes 
below the nuclei. 
 
Figure 2. RPE functions. 
(A) POS phagocytosis requires receptors on the RPE surface. POS are bound by v5 
integrin and the scavenger receptor CD36 mediates POS uptake by RPE. Internalization of 
POS requires MERTK that is activated through phosphorylation by FAK. One of the 
receptors for MERTK is GAS6. (B) Visual cycle is initiated by the hit of rhodopsin by a 
photon that causes isomerisation of 11-cis-retinal into all-trans-retinal. In the photoreceptor 
outer segment all-trans retinal is exposed to the cytoplasmic membrane surface by ABCA4 
and reduced to all-trans retinol by RDH. all-trans retinol is transported to the RPE by IRBP 
and delivered to CRALBP. RPE can receive all-trans retinol also from the choroidal 
vasculature through interaction between the retinol carrier RBP/TTR complex and the 
STRA6 receptor. The conversion of all-trans retinol to 11-cis retinal requires an enzymatic 
cascade involving LRAT, RPE65 and RDH5. 11-cis retinal then exits the RPE bound to 
IRBP and reconstitutes rhodopsin. (C) Transport mechanisms in the RPE require Na+/K+ 
ATPase and, among several ion channels, Na+-K+-2Cl- and HCO3/Na
+ co-transporters at 
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the apical membrane. The basolateral membrane hosts K+ channels and Cl- channels 
(CFTR and bestrophin 1). H2O transport is mediated by aquaporins. PEDF is secreted at 
the apical side and VEGF-A from the basal side. (D) Melanosomes develop through 
sequential maturation stages. Stage I premelanosomes (st.I) correspond to early 
endosomal vacuoles in which Pmel17 organizes into amyloid-like fibrillar structures, visible 
in stage II unpigmented melanosomes (st.II). Melanogenetic enzymes are transferred to 
the maturing organelles. The deposition of black melanin along the fibers is initiated in 
stage III melanosomes (st.III). Mature stage IV melanosomes (st.IV) are fully pigmented. 
 
Figure 3. Proliferation analyses in retinal neurospheres (RNS) derived from human ciliary 
bodies and in cells differentiated into RPE.  
(A-C) Phase-contrast images and (D-F) BrdU immunostaining of pigmented RNS after 3 (A, 
D), 7 (B, E) and 9 (C, F) days in culture. Proliferation declined with time in culture when 
assessed by BrdU labeling (antibody used 1:8000, Developmental Hybridoma, red, 
arrows). Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI, blue in D-F). (G-L) 
RNS cells were dissociated and seeded on ECM for differentiation into a RPE monolayer 
and analyzed after 7 days (G-H), 14 days (I-J) and 21 days (K-L) of differentiation in vitro. 
Phase-contrast images show the morphology of cells (G, I, K) and immunofluorescence 
images of the same fields show BrdU labeling (red staining in H, J, L). Proliferation was 
not observed in more pigmented and thus more differentiated cells (see insert in panel G, 
where the black arrow indicates BrdU negative cells and red arrows indicate BrdU positive 
cells). (M) Graph with the percentages and standard deviations of proliferating cells at 
different times during RPE differentiation in vitro. d= days in culture. Scale bars (100 m) 
are shown in the immunofluorescence images. 
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Figure 4. Epithelial features of the in vitro differentiated RPE layer.  
Immunofluorescence analysis of RPE markers (red) in differentiated RPE-like cells after 7 
days (A, D, G, J, M, R) and 21 days (B, E, H, K, N) of culture and in the MDCK cell line (C, 
F, I, L, O). Nuclei were stained with DAPI (blue). Epithelial tight-junction protein ZO-1 
(antibody used 1:100, Invitrogen) showed membrane localization in 21 days differentiated 
RPE cells and in MDCK cells (B-C) but not in cells after 7 days in culture (A). Polarization 
of the newly formed epithelium was analyzed by confocal microscopy. β5-integrin 
(antibody used 1:20, Abcam) was detected in RPE cells at 7 and 21 days of differentiation 
(D-E) and in MDCK cells (F); below D, E, F the z-axes images show that β5-integrin 
localizes apically in RPE cells (arrows) above the nuclei stained in blue. Apical localization 
of ezrin (antibody used 1:250, Sigma) was detected in RPE cells at 7 and 21 days of 
differentiation (G-H) as well as in MDCK cells (I); below G, H, I the z-axes images confirm 
that ezrin localizes apically above the nuclei stained in blue. Basolateral localization of 
bestrophin 1 (antibody used 1:1000, Novus Biologicals) was detected in RPE cells at 7 
and 21 days of differentiation (J-K) but not in MDCK cells (L); below J, K, L the z-axes 
images confirm that bestrophin 1 localizes basolaterally in RPE differentiated cells 
(arrows) beneath the nuclei stained in blue. Expression of LRAT (antibody used 1:100, 
kindly provided by Dr. K. Palczewski) was detected in RPE cells at 7 and 21 days of 
differentiation (M-N) but not in MDCK cells (O); below M, N, O the z-axes images confirm 
that LRAT localizes intracellularly in RPE cells. The negative control of 
immunofluorescence (R) was performed in RPE cells at 7 days of differentiation by 
incubation with the Alexa Fluor 568 goat anti-rabbit secondary antibody (Molecular 
Probes). Scale bars are: 100 m (G-H), 50 m (A, B, D, E, I, M, N), 25 m (C, F, O, R) and 
20 m (J, K, L). 3D confocal reconstructions of cells labeled with β5-integrin (P) and 
bestrophin 1 (Q) after 21 days of differentiation confirm apical β5-integrin and basolateral 
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bestrophin 1 localizations. β5-integrin and bestrophin 1 are labeled in red and nuclei are 
shown in blue. 3D analysis was performed with the Huygens professional program.  
 
Figure 5. Expression of RPE specific markers and phagocytosis ability of in vitro 
differentiated RPE. 
(A) Western blot analysis of CRALBP (antibody used 1:1000, Abcam) and RPE65 
(antibody used 1:1000, kindly provided by Dr. M. Redmond) in RNS, adult human RPE 
(ad.RPE) and in in vitro differentiated RPE at 7, 14 and 21 days. Western blots were 
normalized with anti-actin antibodies (1:2000, Millipore). (B) Quantification of western blots 
shown in A defined that CRALBP was expressed at all analyzed times and increased with 
time of differentiation in vitro (black bars). RPE65 was detectable in RNS and only after 21 
days of differentiation (grey bars). Quantification of western blots was performed with the 
Image J software normalizing each sample to actin, and protein levels were compared to 
adult RPE that was set equal to 1. (C) Real time q-PCR analysis of H-MITF mRNA levels. 
No expression was detected in the ciliary body (CB), low expression in RNS and increased 
expression in differentiated cells. Expression of H-MITF was higher in in vitro differentiated 
RPE after 21 days of differentiation compared to adult RPE. (D-E) MITF protein expression 
was analyzed by confocal microscopy. Images are a single optical section passing through 
the nuclei of RPE cells immunostained with anti-MITF antibody (1:1000, Santa Cruz 
Biotechnology, green) after 7 (D) and 14 (E) days of differentiation. MITF co-localized with 
nuclear DAPI staining (blue) after 14 days in culture (E). (F-G) Real-time qPCR of PEDF 
(F) and OA1 (G) transcripts detected expression of these genes in the in vitro RPE only 
after 21 days of differentiation. Real-time qPCR were normalized with S26 ribosomal 
mRNA. (H) Phagocytosis assay: RPE cells, after differentiation in vitro for 21 days, were 
incubated with fluorescein labeled POS (green) for 3 hours. Cells were then labeled with 
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anti-ZO-1 antibody and nuclei were stained with DAPI (blue). Confocal analysis showed no 
co-localization between POS (green) and ZO-1 (red). The lower panel shows the z-axis 
that confirms POS internalization: POS (green arrows) localized between ZO-1 labeled 
tight junctions (red arrows) and nuclei (blue). (I) Histogram representing number of POS 
per cell internalized by RPE cells after 1 and 3 hours of exposure to fluorescein labeled 






ABCA4: ATP-binding cassette subfamily A member 4 
AMD: Age-related Macular Degeneration 
AP-1/AP-3: adaptor-protein complex 1/3 
bFGF: basic fibroblast growth factor 
BrdU: 5-bromo-2'-deoxyuridine 
CFTR: cystic fibrosis transmembrane conductance regulator 
CRALBP:  cellular retinaldehyde-binding protein 
DAPI: 4',6-diamidino-2-phenylindole 
DMEM-F12: Dulbecco's Modified Eagle Medium-Nutrient Mixture F12 
ECM: extracellular matrix from Engelbreth-Holm-Swarm murine sarcoma 
ESCs: embryonic stem cells 
FAK:  Focal Adhesion Kinase  
GAS6: growth arrest specific protein 6 
iPSCs: induced pluripotent stem cells 
IRBP: interphotoreceptor retinoid-binding protein  
LRAT: lecithin:retinol acyltransferase 
MATP: membrane-associated transport protein 
MERTK:  c-mer proto-oncogene tyrosine kinase 
MFG-E8: milk fat globule–EGF 8 
MITF: microphthalmia-associated transcription factor 
MLANA: melan-A 
MYO7A: myosin VIIA 
OA1: ocular albinism type 1 
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OSKM: OCT4 and SOX2 and KLF4 and c-MYC 
OTX2: orthodenticle homolog 2 
PAX6: paired box 6 
PEDF: pigment epithelium-derived factor 
PMEL17: premelanosomal protein 17 
POS: photoreceptor cell outer segments 
PVR: proliferative vitreoretinopathy 
RBP/TTR: retinol-binding protein/transthyretin 
RDH: retinol dehydrogenase 
RNS: retinal neurospheres 
RP: Retinitis Pigmentosa 
RPE: retinal pigment epithelium 
RPE65: retinal pigment epithelium-specific protein 65kDa 
RSCs: retinal stem cells 
STGD: Stargardt’s Disease 
VEGF-A: vascular endothelial growth factor A 
VMD: Vitelliform Macular Distrophy 
ZO-1: zona occludens 1 
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